Suchergebnisse - "Nayak, Surendra Kumar"

PubPharm (21)

11

A Retrospect Study on Thiazole Derivatives as the Potential Antidiabetic Agents in Drug Discovery and Developments

enthalten in: Current drug discovery technologies | 2018

von Khatik, G. | Datusalia, A. | Ahsan, W. | +4

12

Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus

enthalten in: Current drug targets | 2018

von Kaur, P. | Mittal, A. | Nayak, S. | +3

13

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

enthalten in: Current cancer drug targets | 2018

von Nayak, S. | Khatik, G. | Narang, R. | +2

14

Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus

enthalten in: Current drug targets | 2018

von Kaur, P. | Mittal, A. | Nayak, S. | +3

15

2,4-Disubstituted thiazoles as multitargated bioactive molecules

enthalten in: Medicinal chemistry research | 2016

von Arora, P. | Narang, R. | Nayak, S. | +2

16

2,4-Disubstituted thiazoles as multitargated bioactive molecules

enthalten in: Medicinal chemistry research | 2016

von Arora, P. | Narang, R. | Nayak, S. | +2

17

2,4-Disubstituted thiazoles as multitargated bioactive molecules

enthalten in: Medicinal chemistry research | 2016

von Arora, P. | Narang, R. | Nayak, S. | +2

18

Pharmacological characterization of GPR120 ligands

enthalten in: The FASEB Journal | 2013

von NAYAK, S. | Adem, A. | Rasoul, B. | +4

19

p53-Induced apoptosis and inhibitors of p53

enthalten in: Current medicinal chemistry | 2009

von Nayak, S. | Panesar, P. | Kumar, H.

20

ChemInform Abstract: Facile Regiospecific Syntheses of N-α,N-1(τ)-Dialkyl-L-histidines.

enthalten in: ChemInform | 2008

von Nayak, S. | Monga, V. | Kaur, N. | +1